Literature DB >> 12568703

[Low-weight syndrome associated with COPD in our setting].

C Coronel1, M Orozco-Levi, A Ramírez-Sarmiento, J Martínez-Llorens, J Broquetas, J Gea.   

Abstract

UNLABELLED: The high prevalence of chronic obstructive pulmonary disease (COPD) has considerable economic and health-related impact. The consequences arise largely from limitations on a patient's activity and shortened life expectancy. Low body weight has recently been implicated as a factor affecting limitations. Although the reason is not clear, weight loss appears to affect many patients (from 25 to 35% in different series), at least in Europe and North America. However, the situation is thought to be different in the Mediterranean area.
OBJECTIVE: To estimate the prevalence of the low weight syndrome in patients with COPD in our area.
METHODS: COPD patient characteristics monitored by our laboratory over the last two years (2000 and 2001) were reviewed.
RESULTS: The prevalence of a body mass index (BMI) less than 20 kg/m2 was only 6.6% among the 3,126 patients studied. That percentage fell to 3.1% with a cutoff of 18 kg/m2. The figure was even more striking if we consider that half the patients had severe disease (FEV1 < 50% of reference). BMI was directly related to FEV1/FC and CO transfer.
CONCLUSIONS: These results suggest that COPD patients in our geographic area have characteristics that distinguish them from those previously described in other countries. Specifically, the prevalence of low weight syndrome in our area appears to be lower. However, larger studies should be performed to confirm this finding.

Entities:  

Mesh:

Year:  2002        PMID: 12568703     DOI: 10.1016/s0300-2896(02)75294-0

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  2 in total

1.  BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?

Authors:  Cristóbal Esteban; José M Quintana; Javier Moraza; Myriam Aburto; Urko Aguirre; José I Aguirregomoscorta; Susana Aizpiri; Luis V Basualdo; Alberto Capelastegui
Journal:  BMC Med       Date:  2010-05-24       Impact factor: 8.775

2.  Swiss Experience in Therapy With Dual Bronchodilation in Chronic Obstructive Pulmonary Disease in Relation to Self-Reported Physical Functionality.

Authors:  Marc Spielmanns; Michael Tamm; Sebastian Schildge; Arschang Valipour
Journal:  J Clin Med Res       Date:  2021-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.